*Division of Gastroenterology and Hepatology, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya
†Division of Gastroenterology, Kawasaki Medical School, Kurashiki
‡AstraZeneca K.K.
§EP-CRSU Co. Ltd., Osaka, Japan
This study and its corresponding analyses were supported and funded by AstraZeneca K.K., Osaka, Japan. The publication fee for this paper was provided by AstraZeneca K.K., Osaka, Japan.
H.M. is currently receiving grants from Daiichi-Sankyo Co., Ltd., Otsuka Pharmaceutical Co., Ltd., and Takeda Pharmaceutical Co., Ltd., and lecture/other fees from AstraZeneca K.K., Daiichi Sankyo Co., Ltd., Otsuka Pharmaceutical Co., Ltd., and Takeda Pharmaceutical Co., Ltd. A.S. is currently receiving grants from Daiichi Sankyo Co., Ltd. and Takeda Pharmaceutical Co., Ltd., research grants from AstraZeneca K.K., and lecture/other fees from Daiichi Sankyo Co., Ltd. and Takeda Pharmaceutical Co., Ltd. M.T., M.E., and T.Y. is full-time employees of AstraZeneca K.K., Osaka, Japan. T.K. is a full-time employee of EP-CRSU Co., Ltd, Tokyo, Japan of which AstraZeneca is a client.
Address correspondence to: Toshitaka Yajima, MD, PhD, Department of Cardiovascular, Renal, and Metabolism, Medical Affairs, AstraZeneca K.K. Osaka Japan, Tower B Gran Front Osaka, 3-1 Ofukacho, Kita-ku, Osaka-shi, Osaka 530-0011, Japan (e-mail: [email protected]).
Received January 25, 2022
Accepted February 1, 2022
This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0/